Emildap S 10/100 Tablets: A Powerful Combination for Type 2 Diabetes Management

Emildap S 10/100 Tablet combines two powerful medications to effectively manage type 2 diabetes: Dapagliflozin (10mg) + Sitagliptin (100mg). This combination provides a comprehensive approach to lowering blood sugar levels and improving glycemic control.

Emildap S utilizes Dapagliflozin's proven ability to increase glucose excretion through the kidneys, reducing blood glucose levels while helping maintain proper kidney function.
Sitagliptin further helps reduce postprandial hyperglycemia (blood sugar spike after meals) by inhibiting pancreatic enzymes involved in insulin release, promoting efficient glucose regulation.

This tablet formulation is conveniently designed for daily use with a specific dosage of Dapagliflozin and Sitagliptin, making it a reliable solution for managing type 2 diabetes symptoms. Always consult your healthcare provider before starting or changing any medications.

Note: This description serves as a general overview. Consult the product label and/or medical professional for comprehensive details on dosage, precautions, and potential side effects.